EP Patent

EP0444897A1 — Novel immunosuppressive cyclosporin analogs with modified amino acids at position-8

Assigned to Merck and Co Inc · Expires 1991-09-04 · 35y expired

What this patent protects

New immunosuppressive cyclosporin analogs are disclosed consisting of [dehydro-Ala]<8> cyclosporins and derived therefrom cyclosporins having a sulfur containing amino acid at position-8.

USPTO Abstract

New immunosuppressive cyclosporin analogs are disclosed consisting of [dehydro-Ala]<8> cyclosporins and derived therefrom cyclosporins having a sulfur containing amino acid at position-8.

Drugs covered by this patent

Patent Metadata

Patent number: EP0444897A1
Jurisdiction: EP
Classification: —
Expires: 1991-09-04
Drug substance claim: No
Drug product claim: No
Assignee: Merck and Co Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.